Clinical impact of forced vital capacity on exercise performance in patients with chronic obstructive pulmonary disease.

6-min-walk test (6MWT) Chronic obstructive pulmonary disease (COPD) forced vital capacity (FVC)

Journal

Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916

Informations de publication

Date de publication:
Feb 2021
Historique:
entrez: 15 3 2021
pubmed: 16 3 2021
medline: 16 3 2021
Statut: ppublish

Résumé

Forced vital capacity (FVC) has been suggested to be a good biomarker for decreased exercise performance in patients with chronic obstructive pulmonary disease (COPD). However, as FVC is highly correlated with forced expiratory volume in 1 second (FEV We performed a cross-sectional study using data from the Korean COPD Subgroup Study (KOCOSS) cohort. We evaluated 1,386 patients with moderate (n=895) and severe-to-very severe (n=491) COPD. Reduced FVC was defined as FVC <80% predicted and short 6MWD as <350 m. Multivariable logistic regression was used to evaluate the association between reduced FVC and short 6MWD. There were no significant differences in respiratory symptoms and quality of life between the patients with reduced FVC and those with preserved FVC. However, patients with reduced FVC had shorter 6MWD (30.5 cm in moderate and 34.5 cm in severe-to-very severe COPD) and higher BODE index scores than those with preserved FVC. The cubic spline model revealed 6MWD peaked around 93% predicted of FVC in moderate COPD, whereas FVC showed a positive association with 6MWD in severe-to-very severe COPD. Multivariable analyses showed that reduced FVC was significantly associated with short 6MWD in both moderate [adjusted odds ratio (aOR) =1.44, 95% confidence interval (CI): 1.03-2.02] and severe-to-very severe (adjusted OR =1.55, 95% CI: 1.01-2.40) COPD. Reduced FVC was significantly associated with shorter 6MWD in moderate-to-very severe COPD patients, suggesting that reduced FVC might be reflective of 6MWD-measured exercise capacity in moderate-to-very severe COPD.

Sections du résumé

BACKGROUND BACKGROUND
Forced vital capacity (FVC) has been suggested to be a good biomarker for decreased exercise performance in patients with chronic obstructive pulmonary disease (COPD). However, as FVC is highly correlated with forced expiratory volume in 1 second (FEV
METHODS METHODS
We performed a cross-sectional study using data from the Korean COPD Subgroup Study (KOCOSS) cohort. We evaluated 1,386 patients with moderate (n=895) and severe-to-very severe (n=491) COPD. Reduced FVC was defined as FVC <80% predicted and short 6MWD as <350 m. Multivariable logistic regression was used to evaluate the association between reduced FVC and short 6MWD.
RESULTS RESULTS
There were no significant differences in respiratory symptoms and quality of life between the patients with reduced FVC and those with preserved FVC. However, patients with reduced FVC had shorter 6MWD (30.5 cm in moderate and 34.5 cm in severe-to-very severe COPD) and higher BODE index scores than those with preserved FVC. The cubic spline model revealed 6MWD peaked around 93% predicted of FVC in moderate COPD, whereas FVC showed a positive association with 6MWD in severe-to-very severe COPD. Multivariable analyses showed that reduced FVC was significantly associated with short 6MWD in both moderate [adjusted odds ratio (aOR) =1.44, 95% confidence interval (CI): 1.03-2.02] and severe-to-very severe (adjusted OR =1.55, 95% CI: 1.01-2.40) COPD.
CONCLUSIONS CONCLUSIONS
Reduced FVC was significantly associated with shorter 6MWD in moderate-to-very severe COPD patients, suggesting that reduced FVC might be reflective of 6MWD-measured exercise capacity in moderate-to-very severe COPD.

Identifiants

pubmed: 33717557
doi: 10.21037/jtd-20-1098a
pii: jtd-13-02-837
pmc: PMC7947547
doi:

Types de publication

Journal Article

Langues

eng

Pagination

837-846

Informations de copyright

2021 Journal of Thoracic Disease. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd-20-1098a). KSJ serves as an unpaid editorial board member of Journal of Thoracic Disease. The authors have no other conflicts of interest to declare.

Références

Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
Am J Respir Crit Care Med. 2003 Feb 15;167(4):544-9
pubmed: 12446268
Am J Respir Crit Care Med. 2009 Mar 15;179(6):509-16
pubmed: 19136371
Eur Respir J. 2014 Nov;44(5):1199-209
pubmed: 25063247
J Thorac Dis. 2019 Apr;11(4):1316-1324
pubmed: 31179073
Eur Respir J. 2014 Dec;44(6):1447-78
pubmed: 25359356
Thorax. 2007 Apr;62(4):291-8
pubmed: 17099077
Int J Chron Obstruct Pulmon Dis. 2018 Feb 28;13:717-724
pubmed: 29535512
J Clin Diagn Res. 2015 Aug;9(8):OC01-4
pubmed: 26435980
Am J Respir Crit Care Med. 2016 Apr 1;193(7):727-35
pubmed: 26540012
Chest. 2016 Jan;149(1):238-51
pubmed: 26356330
Chest. 2012 Jan;141(1):111-120
pubmed: 21659430
Eur Respir J. 2013 Sep;42(3):647-54
pubmed: 23258783
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Int J Tuberc Lung Dis. 2013 Jan;17(1):67-75
pubmed: 23232006
Ann Phys Rehabil Med. 2017 Nov;60(6):387-392
pubmed: 28797622
Chronic Obstr Pulm Dis. 2015 Jul 8;2(4):321-342
pubmed: 28848854
Thorax. 2006 Sep;61(9):772-8
pubmed: 16738033
Chest. 2007 Aug;132(2):456-63
pubmed: 17646240
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Respir Care. 2016 Apr;61(4):475-82
pubmed: 26884447
Eur Respir J. 2010 Nov;36(5):1002-6
pubmed: 20562119
Eur Respir J. 2014 Nov;44(5):1107-9
pubmed: 25362116
Ann Am Thorac Soc. 2015 Mar;12(3):349-56
pubmed: 25568929
N Engl J Med. 2004 Mar 4;350(10):1005-12
pubmed: 14999112
Chest. 2008 Oct;134(4):712-718
pubmed: 18625672
Chest. 2011 Aug;140(2):331-342
pubmed: 21273294
Eur Respir J. 2010 Aug;36(2):292-300
pubmed: 20075059
Eur Respir J. 2016 Feb;47(2):429-60
pubmed: 26797036
Medicine (Baltimore). 2015 Nov;94(47):e2089
pubmed: 26632722
Eur Respir J. 2009 Sep;34(3):648-54
pubmed: 19720809
Am J Respir Crit Care Med. 2016 Dec 15;194(12):1483-1493
pubmed: 27332504

Auteurs

Seong Mi Moon (SM)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea.

Jun Hyeok Lim (JH)

Division of Pulmonology, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, South Korea.

Yun Soo Hong (YS)

Department of Epidemiology and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.

Kyeong-Cheol Shin (KC)

Division of Pulmonology and Allergy, Regional Center for Respiratory Disease, Yeungnam University Medical Center, Daegu, South Korea.

Chang Youl Lee (CY)

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Chuncheon Sacred Heart Hospital, Hallym University, Chuncheon, Gangwon-do, South Korea.

Do Jin Kim (DJ)

Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, South Korea.

Sang Haak Lee (SH)

Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, Department of Internal Medicine, The Catholic University of Korea, Seoul, South Korea.

Ki Suck Jung (KS)

Division of Pulmonary Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University Medical School, Anyang, South Korea.

Chang-Hoon Lee (CH)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.

Kwang Ha Yoo (KH)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, South Korea.

Hyun Lee (H)

Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea.

Hye Yun Park (HY)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Classifications MeSH